Navigation Links
Second annual Brain Tumor Biotech Summit 2013 at Weill Cornell
Date:6/7/2013

NEW YORK (June 7, 2013) -- The nation's leading brain tumor and biotech industry experts again joined forces Friday, June 7, in a bid to accelerate more effective treatments for brain tumors and promote funding for the latest emerging therapies, as the Weill Cornell Brain and Spine Center and Voices Against Brain Cancer hosted its second annual Brain Tumor Biotech Summit.

"Regardless of our backgrounds, our shared vision and purpose today was to bridge the gap between basic and clinical science," says Dr. John Boockvar, chair of the Summit, director of the Brain Tumor Research Group, professor of neurological surgery at Weill Cornell Medical College and a neurosurgeon at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. "It often takes decades to realize discoveries from bench to bedside when it needs to be a few years. This dynamic meeting advanced collaborations vital to accelerating the translation of new scientific findings into novel therapeutics that can be delivered rapidly to our patients."

More than 23,000 people in the United States will be diagnosed with brain or spinal tumors this year and more than 14,000 patients will succumb to their disease, according to the American Cancer Society. With the patient median survival rate of 15 months, there is a crucial need to identify more effective treatments for brain tumors that will not only extend life, but also lead to potential cures.

"Brain cancer touches the lives of thousands of families a year, and it is incumbent upon us to devise novel treatments and therapeutics that will better target malignant tumors and enhance human health," adds Dr. Lewis Cantley, the Margaret and Herman Sokol Professor in Oncology Research and professor of cancer biology in medicine at Weill Cornell and director of the Cancer Center at Weill Cornell and NewYork-Presbyterian Hospital. "However, as federal funding for research has plummeted -- hastened under sequestration -- it is become more important than ever for brain tumor researchers to supplement their government grants with private funding to advance their research."

Industry leaders from the biotech industry, venture capital firms, finance, non-profit foundations and pharmaceutical companies participated in the Brain Tumor Biotech Summit discussions regarding ways to get new research findings noticed and funded. Top brain tumor researchers from across the country presented their latest advances in vaccine treatments, nanotechnology, stem cell biology, angiogenesis, gene therapy, targeted therapeutics, novel medical devices and a host of other topics relevant to the diagnosis and treatment of human cancer.

"The Brain Tumor Biotech Summit is the only place that interfaces scientists, clinicians, financial investors and the biotech industry. I know of no other place that brings those four groups together," says Franklin Berger, a leading biotech industry expert and moderator of the "VC Roundtable: How to Get Your Research or Company Noticed? Lessons from the Investment Experts" panel discussion at the Summit. "That's critical because the cost and time required to get a therapy across the finish line, from thought to vial, is longer and more complex than ever."

The Summit also represents a new way to engage academia, industry and investors in collaborative research. Not only are experts at Weill Cornell adopting the approach for other key areas of neurosurgery, including concussion, spinal cord injury and stroke, but other institutions are also replicating the format to spur research within their own facilities.

"The Summit is an amalgamation of thought leaders in the areas of science, industry and venture capital who collectively have already expanded the boundaries in brain tumor research, leading to novel ideas and new clinical trials. This year's Summit forged new, game-changing relationships, and I'm excited to see the advancements in brain tumor treatments that will be catalyzed as a result," says Dr. Philip E. Stieg, professor and chairman of neurological surgery at Weill Cornell Medical College and neurosurgeon-in-chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.


'/>"/>

Contact: Gerard Farrell
gerard.farrell@hkstrategies.com
212-885-0487
Weill Cornell Medical College
Source:Eurekalert

Related medicine news :

1. Minnesota Becomes the Second State to Pass a Homeowners Bill of Rights
2. Secondhand smoke causes longer hospitalization in infants with respiratory infections
3. Reclaim Skin's Youth in 60 Seconds with Bi-Matrix™
4. Natures Best Cleaners in Sunnyvale Open Second Location in Fremont
5. eHealthcare Solutions Hosts Second Annual Publisher Summit
6. Schimenti and Boston University Take A Second Look at Construction Cameras
7. National Mobility Awareness Month Strives to Create Awareness for the Second Year
8. Sandbridge Virginia Beach Real Estate Sales Improve and Becoming A Big Draw for Second Home Investors
9. Magnetic bracelet relieves pain in seconds announces Superior Magnetics
10. Second-generation TAVI device -- Lotus Valve -- shows good performance in REPRISE II
11. San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... 2016 , ... DDi , a Makro company, makes ... its expertise in eClinical Solutions. DDi has built its solution competency with a ... global clients. DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains ...
(Date:2/12/2016)... ... February 12, 2016 , ... The law firm of ... Evangeline Parishes. The purpose of these scholarships is to encourage applicants to pursue ... to seek employment within these two parishes. , “We have available jobs in ...
(Date:2/12/2016)... Falls Church, VA (PRWEB) , ... February 12, 2016 , ... CDRH Enforcement Trends: , ... http://www.fdanews.com/cdrhenforcementtrends , As Winston Churchill said, “Those who don’t learn ... 2015 will show what to expect when they come knocking this year. But that takes ...
(Date:2/12/2016)... Angeles, CA (PRWEB) , ... February 12, 2016 , ... ... With a hectic schedule, a demanding job, and no time to decompress, Rabinowitz found ... she dedicated herself to meditation for its impact on her life, implementing a 20-minute-per-day ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ... Zuckerberg San Francisco General Hospital on April 5-7. The series is a multi-day, ... new habits. The workshops cover a broad range of topics, including coaching skills, ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 12, 2016  Sequent Medical, Inc. announced today that ... evaluate the safety and effectiveness of the WEB™ Aneurysm ... intracranial aneurysms.  Prof Laurent Spelle , MD, Head ... Paris, France and Principal Investigator of the ... France and Germany.  Although patients with ruptured ...
(Date:2/12/2016)... 2016  OMS Supply, a large provider of oral ... today the recent launching of their new company website. ... features that enhance the user experience and enable practitioners ... --> --> Despite the ... that started in early 2016, they have already made ...
(Date:2/11/2016)... Feb. 11, 2016 - ... in Personalized Medicine and Cancer Therapy. - European ... Diagnostic Testing Markets. - Key Diagnostic Testing Markets. ... Molecular Diagnostics in Genetic Testing. - Molecular Diagnostics ... - Over-the-Counter Diagnostic Products World Markets. - ...
Breaking Medicine Technology: